Select Page
Home » Expert Content » Oral Technologies » New Approaches for Macromolecule Oral Delivery

New Approaches for Macromolecule Oral Delivery

Summary: Catalent Pharma Solutions has developed a broad range of advanced oral drug delivery technologies, including a toolkit of technologies based upon the broad application of lipid-based drug delivery systems (LBDDS) for optimum solubility enhancement. Through innovations to the company’s softgel technology, improved delivery of BCS Class II drugs is possible with OptiShell®, whilst OptiGel™ Bio enhances the membrane permeability allowing the non-invasive delivery of biomolecules, or narcotic compounds under a format that helps prevent abuse.

Download the Article